Logo image of RXRX

RECURSION PHARMACEUTICALS-A (RXRX) Stock Earnings & Estimates

NASDAQ:RXRX - US75629V1044 - Common Stock

4.52 USD
-0.11 (-2.38%)
Last: 9/4/2025, 8:00:02 PM
4.58 USD
+0.06 (+1.33%)
Pre-Market: 9/5/2025, 7:02:54 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
RXRX revenue by date.RXRX revenue by date.
39.84M
291.36%
44.575M
11.89%
58.839M
32.00%
73.016M
24.09%
88.345M
20.99%
219.03M
147.93%
EBITDA
YoY % growth
RXRX ebitda by date.RXRX ebitda by date.
-233.97M
-34.19%
-324.458M
-38.68%
-442.51M
-36.38%
-535.798M
-21.08%
-439.375M
18.00%
-398.111M
9.39%
EBIT
YoY % growth
RXRX ebit by date.RXRX ebit by date.
-245.73M
-34.45%
-348.86M
-41.97%
-479.004M
-37.31%
-672.095M
-40.31%
-559.416M
16.77%
-400.103M
28.48%
Operating Margin
RXRX operating margin by date.RXRX operating margin by date.
-616.79%-782.64%-814.09%-920.48%-633.22%-182.67%
EPS
YoY % growth
RXRX eps by date.RXRX eps by date.
-1.37
-12.87%
-1.57
-14.60%
-1.66
-5.73%
-1.61
3.18%
-1.22
24.21%
-0.84
31.06%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.38
-10.40%
-0.35
34.57%
-0.37
25.20%
-0.35
13.76%
-0.32
14.40%
-0.32
8.82%
Revenue
Q2Q % growth
17.323M
-33.58%
23.562M
422.32%
15.734M
6.71%
17.136M
-10.86%
23.426M
35.23%
23.834M
1.15%
EBITDA
Q2Q % growth
-166.668M
-122.79%
-164.526M
-11.71%
-151.47M
11.95%
-156.57M
-17.68%
-146.88M
11.87%
-149.022M
9.42%
EBIT
Q2Q % growth
-161.408M
-64.11%
-142.517M
22.45%
-158.359M
17.25%
-152.736M
13.33%
-145.384M
9.93%
-145.928M
-2.39%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.41
-2.50%
-0.36-0.05-14.85%
Q1 2025
Q2Q % growth
-0.50
-28.21%
-0.540.046.63%
Q4 2024
Q2Q % growth
-0.53
-26.19%
-0.44-0.09-20.37%
Q3 2024
Q2Q % growth
-0.34
20.93%
-0.360.024.76%
Q2 2024
Q2Q % growth
-0.40
-5.26%
-0.410.011.55%
Q1 2024
Q2Q % growth
-0.39
-14.71%
-0.430.049.68%
Q4 2023
Q2Q % growth
-0.42
-35.48%
-0.460.048.24%
Q3 2023
Q2Q % growth
-0.43
-22.86%
-0.39-0.04-9.50%
Q2 2023
Q2Q % growth
-0.38 -0.380.000.47%
Q1 2023
Q2Q % growth
-0.34
-3.03%
-0.350.014.21%
Q4 2022
Q2Q % growth
-0.31
18.42%
-0.30-0.01-4.80%
Q3 2022
Q2Q % growth
-0.35
-25.00%
-0.390.049.10%
Q2 2022
Q2Q % growth
-0.38
-22.58%
-0.380.000.21%
Q1 2022
Q2Q % growth
-0.33
75.19%
0.10-0.43-423.53%
Q4 2021
Q2Q % growth
-0.38 -0.31-0.07-21.48%
Q3 2021
Q2Q % growth
-0.28 -0.290.011.96%
Q2 2021
Q2Q % growth
-0.31 -0.24-0.07-30.25%
RXRX Yearly EPS VS EstimatesRXRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.5 -1 -1.5
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
19.223M
33.34%
15.742M3.481M22.11%
Q1 2025
Q2Q % growth
14.745M
6.89%
18.479M-3.734M-20.21%
Q4 2024
Q2Q % growth
4.511M
-58.58%
19.424M-14.913M-76.78%
Q3 2024
Q2Q % growth
26.082M
147.62%
30.44M-4.358M-14.32%
Q2 2024
Q2Q % growth
14.417M
30.86%
13.522M895K6.62%
Q1 2024
Q2Q % growth
13.794M
13.68%
12.903M891K6.91%
Q4 2023
Q2Q % growth
10.891M
-20.39%
20.76M-9.869M-47.54%
Q3 2023
Q2Q % growth
10.533M
-19.96%
13.127M-2.594M-19.76%
Q2 2023
Q2Q % growth
11.017M
43.64%
12.153M-1.136M-9.35%
Q1 2023
Q2Q % growth
12.134M
127.65%
14.734M-2.6M-17.65%
Q4 2022
Q2Q % growth
13.68M
440.71%
24.48M-10.8M-44.12%
Q3 2022
Q2Q % growth
13.16M
420.16%
7.115M6.045M84.96%
Q2 2022
Q2Q % growth
7.67M
200.78%
5.508M2.162M39.25%
Q1 2022
Q2Q % growth
5.33M
108.20%
85.629M-80.299M-93.78%
Q4 2021
Q2Q % growth
2.53M 6.188M-3.658M-59.11%
Q3 2021
Q2Q % growth
2.53M 2.754M-224K-8.13%
Q2 2021
Q2Q % growth
2.55M
1,242.11%
2.78M-230K-8.27%
RXRX Yearly Revenue VS EstimatesRXRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-19.48% 27.84% -7.93% -7.68%
Revenue-11.55% 15.73% 3.45% -11.27%